California Coal Tar Litigation Stay Sought Pending FDA Petition Review
This article was originally published in The Tan Sheet
Executive Summary
California litigation over the use of coal tar in dandruff shampoos and other OTCs should be stayed pending FDA review of the ingredient's safety, drug distributor Bergen Brunswig tells a San Francisco judge.
You may also be interested in...
Coal tar
FDA response to citizen petition requesting coal tar-containing products be restricted to Rx-only sales expected by Jan. 22. Perry Gottesfeld, a plaintiff in California Proposition 65 litigation against product manufacturers, asked the agency in March to conduct a "formal review" of coal tar's use in shampoo, soap and ointments. Consolidated trial in separate Prop 65 lawsuits brought by the state and Gottesfeld was stayed until Jan. 29 following defense requests the trial be postponed pending FDA's review (1"The Tan Sheet" Sept. 4, p. 16)
Coal tar
FDA response to citizen petition requesting coal tar-containing products be restricted to Rx-only sales expected by Jan. 22. Perry Gottesfeld, a plaintiff in California Proposition 65 litigation against product manufacturers, asked the agency in March to conduct a "formal review" of coal tar's use in shampoo, soap and ointments. Consolidated trial in separate Prop 65 lawsuits brought by the state and Gottesfeld was stayed until Jan. 29 following defense requests the trial be postponed pending FDA's review (1"The Tan Sheet" Sept. 4, p. 16)
Coal tar
FDA response to citizen petition requesting coal tar-containing products be restricted to Rx-only sales expected by Jan. 22. Perry Gottesfeld, a plaintiff in California Proposition 65 litigation against product manufacturers, asked the agency in March to conduct a "formal review" of coal tar's use in shampoo, soap and ointments. Consolidated trial in separate Prop 65 lawsuits brought by the state and Gottesfeld was stayed until Jan. 29 following defense requests the trial be postponed pending FDA's review (1"The Tan Sheet" Sept. 4, p. 16)